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Pulmonary esSmation after liver kansplantation in CF children 
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Long4erm survival in CF has led to revealing extrapulmonary complications 
including bil iary citlhosis (fatal in up to 5% pts prior to the advent of l iver 
transplantation (LTx)). It causes increased morbidity and mortality and LTx is the 
only effect ive therapy. A ims:  Descript ion of the cl inical  mad pulmonary 
characteristics of CF pts considered for LTx. Methods: From 1990 to 2004, 215 pts 
received 241 LTx, of these 4 with CF. Records of all CF pts with LTx were 
reviewed. Results: 4 pts with CF were the recipients of 5 l iver allografts. Mutation 
analysis howed: AF508/AF508, AF508/G542X and AF5081R553X. Two LTx were 
cadaveric, and two from related donors. Mean age at LTx was 9.9 yr (range 7.6 
13.7). Mean survival t ime was 1.7 yr (range 0.2 3.6). Pt 3 who underwent 
retransplant for primary allogratt nonfunction died of systemic multiorgan failure. 
Immtmosuppression was based on routine medicines. Pulmonary function tests 
(PFF) were obtained one year before LTx in 4 and post LTx in 3 pts. 
Pre LTx [% pred] Post LTx [% pred] 
Patients No VC FEV 1 FEF~o VC FEV 1 FEF~o 
1. 82 91 104 78 85 103 
2. 95 104 103 112 193 96 
3. 107 103 59 
4. 65 64 50 69 69 57 
There was no significant deterioration in posttransplant PFTs. Al l  pts had had 
positive sputum cultures before LTx including Staphylcccccus aureus (Sa) (4 pts) 
and Pseudomonas eruginosa (Pa) (2 pts) and posloperatively Pa (3 pts) and Sa (1 
pt). Conclusions: LTx is the acceptable treatment for CF pts with mild to moderate 
pulmonary disease and end stage liver disease, ha our pts PFF improved slightly or 
remained unchanged. Immtmosuppressive agents did not have a deleterious effect 
on pulmonary function. LTx ha carefully selected CF pts offers opporttmity to 
reduce morbidity and to increase quality of life. 
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The assessment of respiratory status in patients with cystic fibrosis: 
bodypletysmography or impulse oscillometry? 
A. Minar  owska 1, M. Kaczmar ski 1, L. Minarowski ~, M. Mrugacz 9
llllrd Department of ChiMren's' Disease, Medical Univemity of Bialystok Pola~ul; 
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Background: The progress of studies over the ventilation mechanisms along with 
dynamic development of novel measurement techniques enabled using this method 
for examination also in patients with cystic fibrosis (CF). Application of appropriate 
technique of measurement is important to asses the advancement of the destruction 
of lung tissue. 
Aim: The aim of the work was to assess the resistance in airway using 
bodypletysmogr aphy and impulse oscillometry (IOS) in group of patients with CE 
Material and methods: The study was performed on group of 18 patients with CF 
(7F, 11M) aged 10 27 yrs (mean age 15,4 yrs) and on group of 45 healthy patients 
(25F, 20M) aged 9 24 yrs (mean age 13,2 yrs). ha both groups bodypletysmography 
and IOS were performed using Jaeger MasterLab and IOS Master Screen apparatus. 
Total airway resistance (Rtot) and resistance at frequency of 5Hz (Rat5Hz) were 
assessed in both groups. Statistical analysis was conducted subsequently. 
Results: Obtained mean values were respectively: Rtot ,4 + 0,26 kPa/l/s, Rat5Hz 
0,58 + 0,32 kPa/l/s (max. 1,31 kPa/l/s) ha studied group and Rtot 0,25 + 0,08 
kPa/l/s, Rat5Hz 0,5 + 0,21 kPa/l/s (max. 0,91 kPa/l/s) ha controls. Correlation 
coefficient of Rat5Hz and Rtot was r 0,8 (p<0,CO1) ha patients with CF. 
Conclusions: Novel examination techniques of airway resistance assessment, l ike 
impulse oscil lometry, mad bodypletysmography are complementary, but in 
burdensome situations IOS has more advantages than bodypletysmography in 
assessing the airway status in patients with CF. 
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RelaSonship between impulse oscillometry (lOS) and spirometric 
indices (SI) in cysSc fibrosis (CF) children 
L. Moreau 1, D. Crenesse 1, F. Berthier 2, M. Alber tini 1 
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The aim of our retrospective study was to determine the relationship between IOS 
data mad spir ometric tests in CF children. Thirty CF children aged 4 19 years have 
performed lung function tests (LFF) in a f ixed sequence ( IOS ,  Spirometry) on 1 
to 7 separate occasions. IOS parameters were respiratory resistance, reactance mad 
impedence at 5 Hz (R5, X5, Zr) mad the resonant frequency (Fres). SI included 
FEV1, MMEF~ 75 and FVC. An  inverse relationship was observed between raw 
values of R5, Zr, Fres and SI respectively, mad X5 correlated positively with these 
SI. Although significant, these correlations were poor. Receiving Operating 
Characteristic curves were constructed to identify cut off points for IOS parameters 
to discriminate between children according to different FEV 1 thresholds (percent of 
predicted values), general ly used to describe the severity of lung function 
impairment as fol lowing : normal, FEV1 > 80% ; mild, FEV1 > 60% ; moderate, 
FEV1 > 40% ; severe, FEV1 < 40%. The results are exploitable only for the two 
first thresholds given the small number of patients for the lowest tbreshold. No 
acceptable cut off points can be found for IOS parameters. Analysis of trends were 
carried out on a subset of 15 patients who repeated LFF on at least 5 separate 
occasions. Contrary to the t ime course of FEV1 who showed a significant 
diminution, none of the IOS indices demonstrated a consistent trend, and there was 
no correlation between the evolution of FEV1 mad that of each IOS parameter. So, 
IOS measurements presented an insufficient sensitivity to detect and follow 
bronchial obstruction in CF patients. 
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Sleep hypoxemia in stable cysSc fibrosis(CF) 
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Vogiat zis 1, S. Zanos 1, S. Nousia Ar  vanit aids 2 
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Background: Sleep hypoxemia due to hypovenfllafion, occurring predominantly in
REM sleep, is the main etiologic factor in the development of cot pulmonale in 
patients with CF. It is important to predict sleep related esamr atiord hypoxia as this 
could hlfluence the t iming of initiation of preventive treatment and minimiz ing the 
load on cardiovascular system. 
Purpose: To identify predictors of sleep hypoxemia in CF patients. 
Methods: We correlate sleep occurring hypoxia and hypopneas/apneas index to 
daytime measurements of lung function, respiratory muscle strength, arterial blood 
gases, echceardiographic measurements and subjective stimation of sleep quality 
in 25 cl inically stable adolescent and adult CF patients (13 M, age 20+6) having 
mild to moderate lung disease. They were administered with the Pittsburgh 
Insomnia Scale. Unattended sleep studies with the Embletta portable s3,slem were 
performed on the same night. A l l  patients underwent PFTs (lung volumes, f low rates 
and diffusing capacity for carbon monoxide), maximal  Inspiratory (P~=) mad 
Expiratory muscle (P~)  pressure measurements, echceardiographic nd arterial 
blood gases evaluation. 
Results: Overnight oximetry demonstrates that mean SpO2 and DLCO% pred were 
highly correlated (r 0.619, p < 0.001), as wel l  as min SpO2 and left ventricle nd 
diastolic diameter(r 0.465, p<0.02). No correlation was found between subjective 
sleep quality and physiologic variables describing disease severity. 
Conclusions: A decrease in lung diffusing capacity for carbon monoxide correlates 
with sleep hypoxemia. In such cases an overnight oximetry might help to reveal 
sleep hypoxemia t an earl ier stage. 
